HEADER STRUCTURAL PROTEIN 29-SEP-21 7SD4 TITLE SARS-COV-2 NUCLEOCAPSID N-TERMINAL DOMAIN (N-NTD) PROTEIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUCLEOPROTEIN; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: N,NUCLEOCAPSID PROTEIN,NC,PROTEIN N; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2; SOURCE 5 ORGANISM_TAXID: 2697049; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS COVID-19, SARS-COV-2, NUCLEOCAPSID PROTEIN, N-TERMINAL DOMAIN, RNA- KEYWDS 2 BINDING DOMAIN, STRUCTURAL PROTEIN EXPDTA SOLID-STATE NMR NUMMDL 10 AUTHOR S.SARKAR,B.RUNGE,R.W.RUSSELL,D.CALERO,S.ZEINALILATHORI,C.M.QUINN, AUTHOR 2 M.LU,G.CALERO,A.M.GRONENBORN,T.POLENOVA REVDAT 5 15-MAY-24 7SD4 1 REMARK REVDAT 4 14-JUN-23 7SD4 1 REMARK REVDAT 3 29-JUN-22 7SD4 1 JRNL REVDAT 2 15-JUN-22 7SD4 1 JRNL REVDAT 1 08-JUN-22 7SD4 0 JRNL AUTH S.SARKAR,B.RUNGE,R.W.RUSSELL,K.T.MOVELLAN,D.CALERO, JRNL AUTH 2 S.ZEINALILATHORI,C.M.QUINN,M.LU,G.CALERO,A.M.GRONENBORN, JRNL AUTH 3 T.POLENOVA JRNL TITL ATOMIC-RESOLUTION STRUCTURE OF SARS-COV-2 NUCLEOCAPSID JRNL TITL 2 PROTEIN N-TERMINAL DOMAIN. JRNL REF J.AM.CHEM.SOC. V. 144 10543 2022 JRNL REFN ESSN 1520-5126 JRNL PMID 35638584 JRNL DOI 10.1021/JACS.2C03320 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR NIH REMARK 3 AUTHORS : SCHWIETERS, KUSZEWSKI, TJANDRA AND CLORE REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7SD4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-OCT-21. REMARK 100 THE DEPOSITION ID IS D_1000259717. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298.15 REMARK 210 PH : 6.2 REMARK 210 IONIC STRENGTH : 50 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 30 MG/ML [U-100% 13C; U-100% REMARK 210 15N] N-NTD, WATER REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D CORD 25 MS; 2D CORD 100 MS; REMARK 210 2D CORD 250 MS; 2D CORD 500 MS; REMARK 210 2D NCACX 25 MS; 2D NCOCX 25 MS; REMARK 210 2D CP RFDR; 2D HNH HETCOR; 2D REMARK 210 HCH HETCOR; 3D HCANH; 3D HCONH REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, NMRPIPE, CCPNMR REMARK 210 ANALYSIS, NMRFAM-SPARKY, X-PLOR REMARK 210 NIH REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 1000 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 217 REMARK 217 SOLID STATE NMR STUDY REMARK 217 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLID REMARK 217 STATE NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 217 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 217 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ASN A 9 -144.36 -170.54 REMARK 500 1 LEU A 26 118.25 74.58 REMARK 500 1 VAL A 34 139.83 -34.71 REMARK 500 1 GLU A 80 44.56 -106.10 REMARK 500 1 LYS A 105 64.79 -104.91 REMARK 500 2 ASN A 10 -141.86 76.33 REMARK 500 2 LEU A 26 110.22 72.50 REMARK 500 2 VAL A 34 137.53 -32.94 REMARK 500 2 LYS A 105 58.97 -107.07 REMARK 500 2 ARG A 111 152.52 -47.05 REMARK 500 3 ASN A 9 -116.94 58.05 REMARK 500 3 LEU A 26 117.18 75.00 REMARK 500 3 VAL A 34 139.45 -33.26 REMARK 500 3 GLU A 80 42.24 -109.32 REMARK 500 3 LYS A 105 54.73 -107.89 REMARK 500 3 ARG A 111 150.28 -44.73 REMARK 500 4 ASN A 9 -80.94 -159.15 REMARK 500 4 LEU A 26 116.88 74.83 REMARK 500 4 VAL A 34 138.88 -33.57 REMARK 500 4 GLU A 80 44.60 -106.72 REMARK 500 4 LYS A 105 64.79 -108.23 REMARK 500 5 ASN A 9 -86.46 -165.88 REMARK 500 5 LEU A 26 123.57 76.08 REMARK 500 5 VAL A 34 134.90 -32.05 REMARK 500 5 GLU A 80 48.38 -107.31 REMARK 500 5 LYS A 105 58.66 -101.46 REMARK 500 6 ASN A 9 -147.27 -170.67 REMARK 500 6 LEU A 26 119.12 72.34 REMARK 500 6 VAL A 34 139.14 -32.96 REMARK 500 6 GLU A 80 62.92 -109.75 REMARK 500 6 LYS A 105 66.74 -103.14 REMARK 500 6 LEU A 121 99.52 -65.57 REMARK 500 7 ASN A 9 -86.93 -166.96 REMARK 500 7 LEU A 26 120.81 77.27 REMARK 500 7 VAL A 34 154.32 -38.26 REMARK 500 7 LYS A 105 65.31 -104.09 REMARK 500 8 ASN A 9 75.34 -168.48 REMARK 500 8 LEU A 26 118.95 77.49 REMARK 500 8 VAL A 34 138.06 -34.26 REMARK 500 8 LYS A 105 60.12 -108.29 REMARK 500 9 ASN A 9 -71.39 -173.02 REMARK 500 9 LEU A 26 109.11 72.56 REMARK 500 9 VAL A 34 137.71 -32.24 REMARK 500 9 GLU A 80 43.57 -101.83 REMARK 500 9 LYS A 105 62.22 -108.12 REMARK 500 10 ASN A 9 -114.41 56.35 REMARK 500 10 LEU A 26 118.16 77.52 REMARK 500 10 VAL A 34 153.56 -38.07 REMARK 500 10 LYS A 105 66.67 -104.23 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30955 RELATED DB: BMRB REMARK 900 SARS-COV-2 NUCLEOCAPSID N-TERMINAL DOMAIN (N-NTD) PROTEIN DBREF 7SD4 A 2 136 UNP P0DTC9 NCAP_SARS2 40 174 SEQADV 7SD4 SER A 1 UNP P0DTC9 EXPRESSION TAG SEQRES 1 A 136 SER ARG ARG PRO GLN GLY LEU PRO ASN ASN THR ALA SER SEQRES 2 A 136 TRP PHE THR ALA LEU THR GLN HIS GLY LYS GLU ASP LEU SEQRES 3 A 136 LYS PHE PRO ARG GLY GLN GLY VAL PRO ILE ASN THR ASN SEQRES 4 A 136 SER SER PRO ASP ASP GLN ILE GLY TYR TYR ARG ARG ALA SEQRES 5 A 136 THR ARG ARG ILE ARG GLY GLY ASP GLY LYS MET LYS ASP SEQRES 6 A 136 LEU SER PRO ARG TRP TYR PHE TYR TYR LEU GLY THR GLY SEQRES 7 A 136 PRO GLU ALA GLY LEU PRO TYR GLY ALA ASN LYS ASP GLY SEQRES 8 A 136 ILE ILE TRP VAL ALA THR GLU GLY ALA LEU ASN THR PRO SEQRES 9 A 136 LYS ASP HIS ILE GLY THR ARG ASN PRO ALA ASN ASN ALA SEQRES 10 A 136 ALA ILE VAL LEU GLN LEU PRO GLN GLY THR THR LEU PRO SEQRES 11 A 136 LYS GLY PHE TYR ALA GLU SHEET 1 AA1 4 LEU A 18 THR A 19 0 SHEET 2 AA1 4 ASP A 65 TYR A 74 -1 O TRP A 70 N LEU A 18 SHEET 3 AA1 4 ILE A 46 ARG A 55 -1 N ARG A 50 O TYR A 71 SHEET 4 AA1 4 ILE A 92 ALA A 96 -1 O VAL A 95 N GLY A 47 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1